1. ALLA AKTIER
  2. NYHETER
  3. Q-LINEA

Q-Linea

Nyheter Q-Linea Nyheter alla bolag

Q-linea presents at Life Science Investor Konference in Copenhagen – new time

Q-linea is participating in the Life Science Investor Konference on April 19, 2023 at the Symbion, Fruebjervej 3, in Copenhagen.

Q-linea’s CEO Jonas Jarvius presents on April 19 at 14:35 - 15:05 (new time) the latest developments and the future of the company. If you want to register as a participant, use this link,
https://www.eventbrite.co.uk/e/life-science-investor-konference-19-april-2023-tickets-513920158027

For more information, please contact:

Jonas Jarvius, CEO, Q-linea AB
Jonas.Jarvius@qlinea.com
+46 (0) 70-323 77 60

Anders Lundin, CFO, Q-linea AB
Anders.Lundin@qlinea.com
+46 (0) 70-600 15 20

About Q-linea

Q-linea is an innovative infection diagnostics company that primarily develops instruments and disposables for rapid and reliable infection diagnostics. Our vision is to help save lives by ensuring antibiotics continue to be an effective treatment for future generations. Q-linea develops and delivers preferred solutions for healthcare providers, enabling them to accurately diagnose and treat infectious disease in the shortest possible time. The company's lead product ASTar® is a fully automated instrument for antibiotic susceptibility testing (AST), giving a susceptibility profile within six hours directly from a positive blood culture. For more information, please visit www.qlinea.com.

Attachments

Q-linea presents at Life Science Investor Konference in Copenhagen – new time

Datum 2023-04-12, kl 11:00
Källa MFN
Bifogade filer
Q-linea presents at Life Science Investor Konference in Copenhagen – new time
Vill du synas här? Kontakta hej@allaaktier.se. Vår sajt har 125 000 sidvisningar och 17 000 unika besökare per månad. Vår discord har 7800 medlemmar. Detta är aktiva sparare med ett stort aktieintresse. Behöver du nå ut till denna målgrupp så hör av dig!